Pharmacological interventions in the Wnt pathway: inhibition of Wnt secretion versus disrupting the protein-protein interfaces of nuclear factors

British Journal of Pharmacology
Dario ZimmerliKonrad Basler

Abstract

Mutations in components of the Wnt pathways are a frequent cause of many human diseases, particularly cancer. Despite the fact that a causative link between aberrant Wnt signalling and many types of human cancers was established more than a decade ago, no Wnt signalling inhibitors have made it into the clinic so far. One reason for this is that no pathway-specific kinase is known. Additionally, targeting the protein-protein interactions needed to transduce the signal has not met with success so far. Complicating the search for and use of inhibitors is the complexity of the cascades triggered by the Wnts and their paramount biological importance. Wnt/β-catenin signalling is involved in virtually all aspects of embryonic development and in the control of the homeostasis of adult tissues. Encouragingly, however, in recent years, first successes with Wnt-pathway inhibitors have been reported in mouse models of disease. In this review, we summarize possible roads to follow during the quest to pharmacologically modulate the Wnt signalling pathway in cancer. This article is part of a themed section on WNT Signalling: Mechanisms and Therapeutic Opportunities. To view the other articles in this section visit http://onlinelibrary.wiley.c...Continue Reading

References

Sep 17, 1992·Nature·S M PowellK W Kinzler
Aug 17, 1999·Biochemical and Biophysical Research Communications·J KoikeM Katoh
Apr 18, 2000·The Journal of Cell Biology·K I Takemaru, R T Moon
May 4, 2002·Nature Cell Biology·Barry ThompsonMariann Bienz
Jun 28, 2002·Cancer Cell·Ashani T WeeraratnaJeffrey M Trent
Jan 16, 2003·Gene·Bingyu Mao, Christof Niehrs
Sep 12, 2003·Developmental Cell·Michael T VeemanRandall T Moon
Feb 12, 2004·Cancer Research·Germaine M CaldwellDion G Morton
Aug 18, 2004·Proceedings of the National Academy of Sciences of the United States of America·Katayoon H EmamiMichael Kahn
Oct 26, 2005·Drug Discovery Today·Michael McMillan, Michael Kahn
May 9, 2006·Cell·Kerstin BartschererMichael Boutros
May 23, 2006·Current Biology : CB·Reto StädeliKonrad Basler
May 11, 2007·Differentiation; Research in Biological Diversity·Sonia Pinho, Christof Niehrs
Sep 4, 2008·Science Signaling·Renée van AmerongenRoel Nusse
Jan 16, 2009·Proceedings of the National Academy of Sciences of the United States of America·Andy J ChienRandall T Moon
Mar 24, 2009·Nature Reviews. Molecular Cell Biology·Christian MosimannKonrad Basler
Jul 22, 2009·Developmental Cell·Bryan T MacDonaldXi He
Sep 18, 2009·Nature·Shih-Min A HuangFeng Cong
Apr 8, 2010·Growth Factors·Rei E I Nakamura, Abigail S Hackam
Jun 17, 2010·Cancer Research·Nagato SatoYataro Daigo
Nov 17, 2010·Genes & Development·Luca GrumolatoStuart A Aaronson
Nov 24, 2011·Developmental Biology·Patrick Herr, Konrad Basler
Dec 17, 2011·Cancer Cell·William E DamskyMarcus Bosenberg

❮ Previous
Next ❯

Citations

Dec 7, 2017·Frontiers in Physiology·Thimios A MitsiadisClaudio Cantù
Dec 14, 2017·British Journal of Pharmacology·Gunnar Schulte, Vitezslav Bryja
Jul 29, 2017·British Journal of Pharmacology·Yung LyouMarian L Waterman
Feb 11, 2020·Experimental & Molecular Medicine·Youn-Sang Jung, Jae-Il Park
Aug 25, 2018·Frontiers in Physiology·Thimios A MitsiadisLucia Jimenez-Rojo
Jun 6, 2019·Frontiers in Oncology·Milea J M TimbergenErik A C Wiemer
Mar 27, 2020·Neural Regeneration Research·Carlos Gonzalez-FernandezFrancisco Javier Rodríguez
Dec 4, 2020·International Journal of Molecular Sciences·Janine Wörthmüller, Curzio Rüegg
Sep 4, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lipika GoyalDan G Duda
Jan 26, 2021·International Journal of Pharmaceutics·Noa Ben Ghedalia-PeledRazi Vago
Apr 26, 2020·Cellular and Molecular Gastroenterology and Hepatology·Anna ProssomaritiLuigi Ricciardiello
Mar 8, 2021·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Karmani ShahBhumika Patel
Oct 22, 2020·Wiley Interdisciplinary Reviews. Systems Biology and Medicine·Simon Söderholm, Claudio Cantù
Jul 2, 2021·The British Journal of Ophthalmology·Sang Joon JungSun Young Jang
Jul 2, 2021·Annual Review of Cell and Developmental Biology·Lauren V AlbrechtEdward M De Robertis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cadherins and Catenins

Cadherins (named for "calcium-dependent adhesion") are a type of cell adhesion molecule (CAM) that is important in the formation of adherens junctions to bind cells with each other. Catenins are a family of proteins found in complexes with cadherin cell adhesion molecules of animal cells: alpha-catenin can bind to β-catenin and can also bind actin. β-catenin binds the cytoplasmic domain of some cadherins. Discover the latest research on cadherins and catenins here.

Adherens Junctions

An adherens junction is defined as a cell junction whose cytoplasmic face is linked to the actin cytoskeleton. They can appear as bands encircling the cell (zonula adherens) or as spots of attachment to the extracellular matrix (adhesion plaques). Adherens junctions uniquely disassemble in uterine epithelial cells to allow the blastocyst to penetrate between epithelial cells. Discover the latest research on adherens junctions here.

Related Papers

Acta Biochimica Et Biophysica Sinica
Xi ChenChunming Liu
Expert Opinion on Therapeutic Targets
Ana SebioHeinz-Josef Lenz
Molecular and Cellular Endocrinology
Annabel BerthonPierre Val
Clinical Pediatric Endocrinology : Case Reports and Clinical Investigations : Official Journal of the Japanese Society for Pediatric Endocrinology
Takuo KubotaKeiichi Ozono
Expert Opinion on Therapeutic Targets
Alex S KiselyovAlexandre V Ivachtchenko
© 2022 Meta ULC. All rights reserved